During the past decade, Eye Center of Northern Colorado conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 7 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 4 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Eye Center of Northern Colorado" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "AcuFocus, Inc." with 3 trials sponsored, "Glaukos Corporation" with 2 trials sponsored, "Kala Pharmaceuticals, Inc." with 2 trials sponsored and "Surface Ophthalmics, Inc." with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Eye Center of Northern Colorado" #1 collaborator was "Allergan" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "ORA, Inc." with 1 trials as a collaborator and "Statistics & Data Corporation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Eye Center of Northern Colorado" are "Presbyopia" (3 trials), "Dry Eye Disease" (2 trials), "Neovascular Age-Related Macular Degeneration" (2 trials), "Cataract" (1 trials) and "Diabetic Macular Edema" (1 trials). Many other conditions were trialed in "Eye Center of Northern Colorado" in a lesser frequency.

Most popular intervention types in "Eye Center of Northern Colorado" are "Drug" (12 trials), "Device" (5 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Intravitreal Ranibizumab 0.5 mg Injection" (2 trials), "PDS Implant Pre-Filled with 100 mg/mL Ranibizumab" (2 trials), "Placebo" (2 trials), "0.02% Betamethasone Sodium Phosphate" (1 trials) and "0.04% Betamethasone Sodium Phosphate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Eye Center of Northern Colorado" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Eye Center of Northern Colorado". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Eye Center of Northern Colorado, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Eye Center of Northern Colorado, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".